Patient recruitment is ongoing in phase II study of BI-730357 in plaque psoriasis Oct. 2, 2018 No Comments
P. acnes CAMP factor-associated inflammation in acne vulgaris: a potential vaccination strategy Sep. 28, 2018 No Comments
Concert Pharmaceuticals amends protocol of phase IIa trial with CTP-543 in alopecia areata Sep. 27, 2018 No Comments
Patient enrollment ongoing in phase II study of M-1095 in chronic plaque-type psoriasis Sep. 26, 2018 No Comments
Phase II results presented for BMS-986165 in patients with moderate to severe psoriasis Sep. 19, 2018 No Comments
Ilumetri receives approval in Europe for treatment of moderate to severe chronic plaque psoriasis Sep. 19, 2018 No Comments
RSS